Summary of the Warrants (Details) - $ / shares		Jan. 24, 2025	Dec. 31, 2024	Nov. 25, 2024	Mar. 13, 2024	Jul. 31, 2023	May 18, 2023	Apr. 10, 2023
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares			11,221,557
Exercise price				$ 2.85	$ 8.10	$ 7.50		$ 7.50
Minimum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Exercise price						$ 3.50
Minimum [Member] | January 2024 PIPE Warrant [Member] | Subsequent Event [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Exercise price		$ 2.49
Maximum [Member] | January 2024 PIPE Warrant [Member] | Subsequent Event [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Exercise price		$ 2.07
Dragasac Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares	[1],[2]		652,981
Exercise price	[1],[2]		$ 2.4898
Expiration date	[1],[2]		Mar. 16, 2025
Public Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares	[3]		1,437,447
Exercise price	[3]		$ 115.00
Expiration date	[3]		Jul. 16, 2026
Sponsor Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares	[3]		849,999
Exercise price	[3]		$ 115.00
Expiration date	[3]		Jul. 16, 2026
May 2022 Private Investment in Public Equity Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares			405,405
Exercise price			$ 3.50
Expiration date			Oct. 10, 2028
March 2023 Private Investment in Public Equity Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares			208,485
Exercise price			$ 30.00
Expiration date			Mar. 27, 2028
March 2023 Private Investment in Public Equity Warrants, Modified [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares			729,698
Exercise price			$ 10.00
Expiration date			Mar. 27, 2028
March 2023 Loan Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares	[4]		75,000
Exercise price	[4]		$ 5.8950
Expiration date	[4]		Mar. 17, 2028
April 2023 Registered Direct Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares			435,625
Exercise price			$ 7.50
Expiration date			Oct. 10, 2028
April 2023 Registered Direct Warrants Modified [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares			487,451
Exercise price			$ 3.50
Expiration date			Oct. 10, 2028
May 2023 Private Investment in Public Equity Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares			581,394
Exercise price			$ 10.00				$ 10.00
Expiration date			May 17, 2028				May 17, 2028
June 2023 Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares	[4]		50,000
Exercise price	[4]		$ 5.8950
Expiration date			Jun. 20, 2028
June 2023 Loan Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares			300,000
Exercise price			$ 8.10
Expiration date			Jun. 20, 2028
July 2023 Registered Direct Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares			857,142
Exercise price			$ 3.50
Expiration date			Jan. 31, 2029
January 2024 PIPE Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares	[2]		535,274
Exercise price	[2]		$ 2.4898
Expiration date	[2]		Jan. 16, 2029
January 2024 Bridge Loan Tranche One Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares			1,650,000
Exercise price			$ 2.4898
Expiration date			Jan. 16, 2029
January 2024 Bridge Loan - Tranche #2 Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares			1,350,000
Exercise price			$ 2.9880
Expiration date			Jul. 15, 2029
March 2024 RWI Forbearance Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares			300,000
Exercise price			$ 5.8958
Expiration date			Jun. 20, 2028
November 2024 Purchaser Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares			263,156
Exercise price			$ 2.85
November 2024 Purchaser Warrants [Member] | Minimum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Expiration date			Nov. 25, 2029
November 2024 Purchaser Warrants [Member] | Maximum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Expiration date			Dec. 03, 2029
November 2024 Placement Agent Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares			52,500
Exercise price			$ 3.56
November 2024 Placement Agent Warrants [Member] | Minimum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Expiration date			Nov. 25, 2029
November 2024 Placement Agent Warrants [Member] | Maximum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Expiration date			Dec. 03, 2029

[1] In connection with the execution of the January 2024 PIPE described above, the Company agreed to reprice 652,981 legacy warrants held by Dragasac with a previous exercise price of $67.70 to a new exercise price of $2.4898. The term of the warrants was unchanged.

[2] On January 24, 2025, the Company agreed to reduce the exercise price of the Dragasac warrants and the January 2024 PIPE warrants from $2.49 per share to $2.07 per share. As a result of the price reduction, the holder agreed to immediately exercise the warrants in full and to purchase an aggregate 1,188,255 shares of the Company’s Class A common stock for gross proceeds to the Company of approximately $2.5 million.

[3] The number of Public Warrants and Sponsor Warrants outstanding was not adjusted for the reverse stock split. There are 14,374,478 Public Warrants and 8,499,999 Sponsor Warrants outstanding. After the reverse stock split, the number of warrants outstanding remains the same. However, each outstanding warrant is now exercisable for one-tenth of a share of Class A common stock, and the exercise price per share was adjusted to $115.00 as a result of the split.

[4] In connection with the execution of the Starr Forbearance Agreement on March 13, 2024, described above under Warrant Modification and further in Note 10, the Company agreed to reprice 75,000 warrants with a previous exercise price of $7.10 and 50,000 warrants with a previous exercise price of $8.10 held by C.V. Starr to a new exercise price of $5.895. The term of the warrants was unchanged.